{"id":"https://openalex.org/W2186801162","doi":"https://doi.org/10.1093/cvr/cvv227","title":"The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials","display_name":"The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-25","ids":{"openalex":"https://openalex.org/W2186801162","doi":"https://doi.org/10.1093/cvr/cvv227","mag":"2186801162","pmid":"https://pubmed.ncbi.nlm.nih.gov/26410367"},"language":"en","primary_location":{"id":"doi:10.1093/cvr/cvv227","doi":"https://doi.org/10.1093/cvr/cvv227","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cvr/cvv227","pdf_url":null,"source":{"id":"https://openalex.org/S91067379","display_name":"Cardiovascular Research","issn_l":"0008-6363","issn":["0008-6363","1755-3245"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2186801162"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062214319","display_name":"Gabriella Passacquale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I32003884","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I32003884"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gabriella Passacquale","raw_affiliation_strings":["Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK gabriella.passacquale@kcl.ac.uk albert.ferro@kcl.ac.uk","Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK gabriella.passacquale@kcl.ac.uk albert.ferro@kcl.ac.uk","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I32003884"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I32003884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030015829","display_name":"Paolo Di Giosia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I32003884","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I32003884"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paolo Di Giosia","raw_affiliation_strings":["Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I32003884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045722303","display_name":"Albert Ferro","orcid":"https://orcid.org/0000-0002-5486-9145","observed_orcids":["https://orcid.org/0000-0002-5486-9145"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I32003884","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I32003884"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Albert Ferro","raw_affiliation_strings":["Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I32003884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062214319"],"corresponding_institution_ids":["https://openalex.org/I183935753","https://openalex.org/I32003884"],"apc_list":{"value":4715,"currency":"EUR","value_usd":5329},"apc_paid":null,"fwci":0.674,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.56848485,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"109","issue":"1","first_page":"9","last_page":"23"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.7860999703407288,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.7860999703407288,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.14560000598430634,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.031099999323487282,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cardiovascular-inflammation","display_name":"cardiovascular inflammation","score":0.8009999990463257},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.8169999718666077},{"id":"https://openalex.org/keywords/residual-cardiovascular-risk","display_name":"residual cardiovascular risk","score":0.8429999947547913},{"id":"https://openalex.org/keywords/secondary-prevention-of-cardiovascular-disease","display_name":"secondary prevention of cardiovascular disease","score":0.7400000095367432},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.7799999713897705},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.8989999890327454},{"id":"https://openalex.org/keywords/phospholipase-a2-inhibitors","display_name":"phospholipase A2 inhibitors","score":0.949999988079071},{"id":"https://openalex.org/keywords/antioxidants","display_name":"antioxidants","score":0.9679999947547913},{"id":"https://openalex.org/keywords/patient-subgroup-identification","display_name":"patient subgroup identification","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8102416396141052},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.7497013211250305},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5697236061096191},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5249785780906677},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.496282160282135},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.48945796489715576},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.46870535612106323},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.42918241024017334},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3564906418323517},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33120930194854736},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008077","descriptor_name":"Lipoproteins, LDL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018946","descriptor_name":"Chemokine CCL5","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D064801","descriptor_name":"Phospholipase A2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/cvr/cvv227","doi":"https://doi.org/10.1093/cvr/cvv227","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cvr/cvv227","pdf_url":null,"source":{"id":"https://openalex.org/S91067379","display_name":"Cardiovascular Research","issn_l":"0008-6363","issn":["0008-6363","1755-3245"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Research","raw_type":"journal-article"},{"id":"pmid:26410367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26410367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2730352675","display_name":"Anti-atherogenic effects of anti-platelet drugs in patients with silent atherosclerosis","funder_award_id":"FS/13/45/30345","funder_id":"https://openalex.org/F4320319992","funder_display_name":"British Heart Foundation"},{"id":"https://openalex.org/G3099830349","display_name":null,"funder_award_id":"CL-2011-17-002","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320319992","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":101,"referenced_works":["https://openalex.org/W92308566","https://openalex.org/W110542923","https://openalex.org/W150221401","https://openalex.org/W1572528121","https://openalex.org/W1586079541","https://openalex.org/W1685305421","https://openalex.org/W1891655359","https://openalex.org/W1923917571","https://openalex.org/W1948676867","https://openalex.org/W1965859404","https://openalex.org/W1966100182","https://openalex.org/W1969903594","https://openalex.org/W1977199590","https://openalex.org/W1986216490","https://openalex.org/W1989786519","https://openalex.org/W1999264494","https://openalex.org/W2006323569","https://openalex.org/W2011232682","https://openalex.org/W2011768933","https://openalex.org/W2015141049","https://openalex.org/W2017424062","https://openalex.org/W2017619851","https://openalex.org/W2024378513","https://openalex.org/W2026578487","https://openalex.org/W2026651190","https://openalex.org/W2031438601","https://openalex.org/W2032374475","https://openalex.org/W2035817205","https://openalex.org/W2037311267","https://openalex.org/W2041166449","https://openalex.org/W2044161694","https://openalex.org/W2044710565","https://openalex.org/W2045771190","https://openalex.org/W2048380290","https://openalex.org/W2048637181","https://openalex.org/W2048844353","https://openalex.org/W2057835664","https://openalex.org/W2058670466","https://openalex.org/W2062834355","https://openalex.org/W2063028221","https://openalex.org/W2064255959","https://openalex.org/W2064422582","https://openalex.org/W2069370313","https://openalex.org/W2071498411","https://openalex.org/W2073054137","https://openalex.org/W2073590197","https://openalex.org/W2074115529","https://openalex.org/W2075619622","https://openalex.org/W2082830616","https://openalex.org/W2083217753","https://openalex.org/W2083788937","https://openalex.org/W2084158483","https://openalex.org/W2084235819","https://openalex.org/W2089573422","https://openalex.org/W2092261570","https://openalex.org/W2098879265","https://openalex.org/W2101016903","https://openalex.org/W2105594104","https://openalex.org/W2110551379","https://openalex.org/W2111443452","https://openalex.org/W2113187337","https://openalex.org/W2116422482","https://openalex.org/W2118154631","https://openalex.org/W2118968774","https://openalex.org/W2119475547","https://openalex.org/W2124964328","https://openalex.org/W2128901862","https://openalex.org/W2129942624","https://openalex.org/W2131615550","https://openalex.org/W2131872763","https://openalex.org/W2132128152","https://openalex.org/W2137983259","https://openalex.org/W2141715624","https://openalex.org/W2143727405","https://openalex.org/W2145053304","https://openalex.org/W2145916551","https://openalex.org/W2145979546","https://openalex.org/W2146461935","https://openalex.org/W2148609678","https://openalex.org/W2149991612","https://openalex.org/W2151223394","https://openalex.org/W2151729372","https://openalex.org/W2152043519","https://openalex.org/W2152766689","https://openalex.org/W2154467978","https://openalex.org/W2155856725","https://openalex.org/W2158380859","https://openalex.org/W2158550197","https://openalex.org/W2158667202","https://openalex.org/W2161713085","https://openalex.org/W2161913081","https://openalex.org/W2163092745","https://openalex.org/W2165241435","https://openalex.org/W2168756469","https://openalex.org/W2170973130","https://openalex.org/W2316376271","https://openalex.org/W2735267600","https://openalex.org/W2764031540","https://openalex.org/W2775794168","https://openalex.org/W3022401702","https://openalex.org/W6672829087"],"related_works":["https://openalex.org/W4417221659","https://openalex.org/W2517363074","https://openalex.org/W7134238932","https://openalex.org/W2947957797","https://openalex.org/W3022959031","https://openalex.org/W7204442067","https://openalex.org/W4414853972","https://openalex.org/W2804409796","https://openalex.org/W1991403773","https://openalex.org/W7201953620"],"abstract_inverted_index":{"Anti-inflammatory":[0],"add-on":[1],"therapy":[2],"to":[3,15,58,62,91,148,177],"conventional":[4,127],"cardiovascular":[5,19,76,136],"prophylaxis":[6],"has":[7,23,143],"been":[8,24],"proposed":[9],"as":[10,152],"a":[11,27,135,153],"novel":[12,41],"therapeutic":[13],"approach":[14],"potentially":[16],"reduce":[17,63],"residual":[18],"risk.":[20],"This":[21,142],"hypothesis":[22],"challenged":[25],"by":[26],"series":[28],"of":[29,40,50,56,100,113,116,156,158,166,173,180,187,197,217],"unsuccessful":[30],"Phase":[31,67],"III":[32],"studies":[33,90],"testing":[34],"the":[35,47,97,101,111,150,159,164,171,181,215],"impact":[36],"on":[37,96,214],"clinical":[38],"outcomes":[39],"agents":[42,84],"with":[43,211],"immunomodulatory":[44],"actions.":[45],"Specifically,":[46],"apparent":[48],"ability":[49],"phospholipase":[51],"A2":[52],"(PLA2)":[53],"inhibitors":[54],"and":[55,61,106,129,221],"antioxidants":[57],"ameliorate":[59],"inflammation":[60],"coronary":[64],"disease":[65],"in":[66,78,118,163,194,208],"II":[68],"trials":[69],"did":[70],"not":[71],"translate":[72],"into":[73],"improved":[74],"secondary":[75],"prevention":[77,137],"larger":[79],"population-based":[80],"studies.":[81],"Other":[82],"anti-inflammatory":[83,161,189],"are":[85],"still":[86],"under":[87],"scrutiny.":[88],"However,":[89],"date":[92],"have":[93],"lacked":[94],"information":[95],"inflammatory":[98,204],"profile":[99],"participants,":[102],"both":[103],"at":[104,107],"baseline":[105],"follow-up,":[108],"thereby":[109],"limiting":[110],"possibility":[112],"identifying":[114],"subgroups":[115,196],"patients":[117],"whom":[119],"'residual":[120],"inflammation'":[121],"can":[122,191],"be":[123,192],"detected":[124],"despite":[125],"optimal":[126],"therapy,":[128],"who":[130],"could":[131,206],"therefore":[132],"benefit":[133],"from":[134],"strategy":[138],"specifically":[139],"targeting":[140],"inflammation.":[141],"also":[144,200],"rendered":[145],"it":[146],"difficult":[147],"interpret":[149],"results":[151],"conclusive":[154],"demonstration":[155],"inefficacy":[157],"tested":[160],"strategies":[162,190],"treatment":[165],"atherosclerosis.":[167],"We":[168,199],"here":[169],"discuss":[170],"importance":[172],"better":[174],"patient":[175],"characterization":[176],"minimize":[178],"heterogeneity":[179],"study":[182],"population,":[183],"so":[184],"that":[185],"effectiveness":[186],"different":[188],"evaluated":[193],"targeted":[195],"patients.":[198],"illustrate":[201],"how":[202],"specific":[203],"biomarkers":[205],"assist":[207],"this":[209],"process,":[210],"particular":[212],"emphasis":[213],"roles":[216],"high-sensitivity":[218],"C-reactive":[219],"protein":[220],"circulating":[222],"monocyte":[223],"phenotype.":[224]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2186801162","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
